Sharon M. Kelly, Ph.D.

Sharon M. Kelly, Ph.D.
Sharon M. Kelly, Ph.D.
Research Scientist

Ph.D., Sociology: Justice, American University
skelly@friendsresearch.org
Phone: 410-837-3977 ext. 273
Fax: 410-752-4218
Research Interests

Dr. Kelly’s research experience has focused on investigating ways of improving substance abuse treatment services, implementation, and delivery for opioid-dependent individuals, particularly for adults involved with the criminal justice system. Specifically, her research has explored factors surrounding treatment entry and engagement for individuals in treatment as well as for individuals who are not currently in treatment, gender differences among individuals in and out of treatment, and patient satisfaction as it relates to retention in treatment and decreased drug use and illegal activity. Currently, Dr. Kelly works as Co-Investigator and Project Manager on the National Institute on Drug Abuse-funded study “A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail” which compares the effectiveness of three approaches to opioid use disorder treatment started in the Baltimore City Detention Center.

Selected Publications
Dunlap LJ, Zarkin GA, Orme S, Meinhofer A, Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Schwartz RP (2018). Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment. Journal of Substance Abuse Treatment. 94:81-90. doi: 10.1016/j.jsat.2018.07.014. Epub 2018 Jul 31. PMID: 30243422.
Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff's views of patient-centered methadone treatment: Changing program rules and staff roles. The Journal of Behavioral Health Services and Research. 45(3):506-515. doi: 10.1007/s11414-018-9603-1. PMID: 29536342.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2017). Patient‐centered methadone treatment: a randomized clinical trial. Addiction. 112(3):454-64.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2017). When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records. Drug and Alcohol Dependence. 180:385-390. doi: 10.1016/j.drugalcdep.2017.08.025. Epub 2017 Sep 14. PMID: 28961545.
Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2017). Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current Psychiatry Reports. 19(6):35. doi: 10.1007/s11920-017-0783-9. Review. PMID: 28526967.
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O’Grady KE, Lee J (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials. 48:166-72. doi: 10.1016/j.cct.2016.05.003. PMID: 27180088.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Corrigendum to “Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial”. Contemporary Clinical Trials. 51:97. doi: 10.1016/j.cct.2016.09.008. PMID: 27729206.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Contemporary Clinical Trials. 49:21-8. doi: 10.1016/j.cct.2016.06.002. PMID: 27282117.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction. doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.
Sharma A, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Substance Abuse and Rehabilitation. 7:27-40. doi: 10.2147/SAR.S81602. Review. PMID: 27217808. PMCID: PMC4853155 DOI: 10.2147/SAR.S81602.
Gryczynski J, Kelly SM, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. Addiction. 110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.
Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O’Grady KE, Jaffe JH (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases. 34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug and Alcohol Dependence. 140:213-6. PubMed PMID: 24793367; PubMed Central PMCID: PMC4070874.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 133(5):819-26. PubMed PMID: 24753528; PubMed Central PMCID: PMC4006430.
Mitchell SG, Gryczynski J, Kelly SM, O’Grady KE, Jaffe JH, Olsen YK, Schwartz RP (2014). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. Journal of Drug Issues. 44(1):69-82. PMID:25364037.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, Schwartz RP (2014). The CRAFFT Cut-Points and DSM-5 Criteria for Alcohol and Other Drugs: A Reevaluation and Reexamination. Substance Abuse. 35(4):376-80. PubMed PMID: 25036144; PubMed Central PMCID: PMC4268117.
Schwartz RP, Alexandre PK, Kelly SM, O’Grady KE, Gryczynski J, Jaffe JH (2014). Interim versus standard methadone treatment: a benefit-cost analysis. Journal of Substance Abuse Treatment. 46(3):306-14. doi: 10.1016/j.jsat.2013.10.003. Epub 2013 Oct 14.PMID:24239030.
Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O’Grady KE, Olsen YK, Schwartz RP (2013). Retention in methadone and buprenorphine treatment among African Americans. Journal of Substance Abuse Treatment. 45(3):287-92.
Kelly SM, O’Grady KE, Jaffe JH, Gandhi D, Schwartz RP (2013). Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment . Journal of Addiction Medicine. 7 (2), 133-138.
Gryczynski J, Kinlock TW, Kelly SM, O’Grady KE, Gordon MS, Schwartz RP (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse. 33 (1), 30-39.
Kelly SM, Brown BS, Katz EC, O’Grady KE, Mitchell SG, King S, Schwartz RP (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients. The American Journal of Drug and Alcohol Abuse. 38 (3), 233-238.
Kelly SM, Schwartz RP, O’Grady KE, Gandhi D, Jaffe JH (2012). Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial. Journal of Addiction Medicine. 6 (2), 145-152. [PMCID: PMC3322294].
Mitchell SG, Kelly SM, Brown BS, O’Grady KE, Schwartz RP (2012). HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults. American Journal of Drug and Alcohol Abuse. 38 (4), 328-333.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O’Grady KE, Olson YK, Schwartz RP (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients. Drug and Alcohol Dependence. 122, 55-60. [PMCID: PMC3251709].
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2012). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction. 107 (5), 943-952. [PMCID: PMC3319854].
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence. 117. (2-3), 170-175. [PMCID: PMC3148301].
Mitchell SG, Morioka R, Reisinger HS, Peterson JA, Kelly SM, Agar MH, Schwartz RP, et al (2011). Redefining retention: recovery from the patient's perspective. Journal of Psychoactive Drugs. 43 (2), 99-107. [PMCID: PMC3160714].
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2011). Interim methadone treatment compared to standard methadone treatment: 4-Month findings. Journal of Substance Abuse Treatment. 41 (1), 21-29. [PMCID: PMC3110526].
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Brown BS (2011). Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts. Drug and Alcohol Dependence. 115 (1-2), 23-29. [PMCID: PMC3059350].
Kelly SM, O’Grady KE, Brown BS, Mitchell SG, Schwartz RP (2010). The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse, 36. (3), 150-154. [PMCID: PMC2938880].
Kelly SM, O’Grady KE, Schwartz RP, Peterson JA, Wilson ME, Brown BS (2010). The relationship of social support to treatment entry and engagement: The community assessment inventory. Substance Abuse. 31 (1), 43-52. [PMCID: PMC2856126].
Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy. 21 36-42. [PMCID: PMC2790538].
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse. 35, 38-42.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE Schwartz RP (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users.  Journal of Psychoactive Drugs.
Schwartz RP, Jaffe JH, O’Grady KE, Kinlock TW, Gordon MS, Kelly SM, Wilson ME, Ahmed A (2009). Interim Methadone Treatment: Impact on Arrests.  Drug and Alcohol Dependence. 103, 148-154. doi: 10.1016/j.drugalcdep.2009.03.007. Epub 2009 May 14. PMID: 19443133.
Peterson JP, Schacht-Reisinger H, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH (2008). Targeted sampling in drug abuse research: A review and case study.  Field Methods. 20(2), 155-170.
Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar MH (2008). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs.
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions. 17(5), 396-401.
Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse. 34(1), 17-28.